Teladoc (4LL) Financial Statements
Teladoc Financial Overview
Teladoc's market cap is currently $1.28B. The company's EPS TTM is $-0.86; its P/E ratio is -9.89; Teladoc is estimated to report earnings on February 23, 2027, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.53B | $ 2.57B | $ 2.60B | $ 2.41B | $ 2.03B |
| Gross Profit | $ 1.76B | $ 1.82B | $ 1.84B | $ 1.66B | $ 1.38B |
| Operating Income | $ -262.95M | $ -1.02B | $ -248.55M | $ -13.65B | $ -265.63M |
| EBITDA | $ 147.30M | $ 174.06M | $ 138.22M | $ 50.32M | $ -19.37M |
| Net Income | $ -200.32M | $ -1.00B | $ -220.37M | $ -13.66B | $ -428.79M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 781.08M | $ 1.30B | $ 1.12B | $ 918.18M | $ 896.02M |
| Total Assets | $ 3.10B | $ 3.52B | $ 4.39B | $ 4.70B | $ 17.73B |
| Total Debt | $ 1.04B | $ 1.58B | $ 1.59B | $ 1.59B | $ 1.28B |
| Net Debt | $ 259.08M | $ 286.29M | $ 468.60M | $ 668.74M | $ 386.65M |
| Total Liabilities | $ 1.72B | $ 2.03B | $ 2.07B | $ 2.39B | $ 1.69B |
| Stockholders' Equity | $ 1.39B | $ 1.49B | $ 2.33B | $ 2.31B | $ 16.05B |
| Cash Flow | |||||
| Free Cash Flow | $ 285.46M | $ 282.89M | $ 193.67M | $ 172.81M | $ 185.46M |
| Operating Cash Flow | $ 294.36M | $ 293.68M | $ 350.02M | $ 189.29M | $ 193.99M |
| Investing Cash Flow | $ -266.00M | $ -124.05M | $ -156.35M | $ -167.74M | $ -72.98M |
| Financing Cash Flow | $ -551.65M | $ 8.31M | $ 10.85M | $ 6.50M | $ 40.95M |
Currency in USD